GS-9667 is a new selective, partial agonist of the A(1) adenosine receptor (AR). It represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA). References: Staehr PM, Dhalla AK, Zack J, Wang X, Ho YL, Bingham J, Belardinelli L. Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist. J Clin Pharmacol. 2013 Apr;53(4):385-92. doi: 10.1002/jcph.9. Epub 2013 Feb 20. PubMed PMID: 23427000.

纯度：≥98%

CAS：618380-90-8